ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: Minthostachys verticillata (Griseb.) Epling (Lamiaceae) is a plant used in folk medicine for digestive or respiratory disorders. In addition, it is incorporated as condiment, in foods, as beverage flavoring or mate. The ethnopharmacological interest of M. verticillata resides in its essential oil (EO). Part of group has demonstrated the immunomodulatory ability of EO giving this oil a biological potential not known until that moment and conducted studies to evaluate their possible application in diseases of veterinary interest. However, the immunomodulatory effects of EO administered orally have not been fully characterized. AIM OF THE STUDY: This study evaluated the impact of EO oral administration on gastrointestinal and immune health through measurement of immunological and oxidative parameters in mice. MATERIAL AND METHODS: The EO was extracted from the leaves, slender stems and flowers of M. verticillata by hydrodistillation and chemical analyzed by gas chromatography-mass spectrometry (GC-MS). Prior to in vivo study, the cytotoxic effect of EO was determined using the human colon carcinoma Caco-2 cell line. For in vivo study, three groups of male Balb/c mice (n = 3) were orally administered with saline solution (control group) and EO (5 or 10 mg/kg/day) during 10 consecutive days. Subsequently, histological and hematological parameters, cytokines production, oxidative markers and CD4+ and CD8+ T cells were evaluated. RESULTS: The chemical analysis of EO revealed the presence of a high content of monoterpenes, being the main pulegone (76.12%) and menthone (14.28%). The EO oral administration improved mice growth performance and modulated systemic adaptive immune response by increasing in the total leukocyte number. A high percentage of CD4+ T cells were observed whereas the number of CD8+ T cells was not altered. EO did not alter the morpho-physiology of intestine and improved total antioxidant capacity by decreasing MDA concentrations. In addition, EO decreased the IL-6 levels and increased in the IL-4 and IL-10 concentrations. CONCLUSION: Results indicate that M. verticillata EO modulate inflammatory and oxidative parameters constituting a natural alternative which could be applied to improve gastrointestinal and immune functionality in animals.
Subject(s)
Digestive System/drug effects , Immune System/drug effects , Lamiaceae , Oils, Volatile/pharmacology , Animals , Blood/drug effects , CD4-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/drug effects , Cell Line, Tumor , Cytokines/drug effects , Dose-Response Relationship, Drug , Humans , Interleukin-10/metabolism , Interleukin-4/metabolism , Interleukin-6/metabolism , Male , Medicine, Traditional , Mice , Mice, Inbred BALB C , Monoterpenes/chemistry , Monoterpenes/pharmacology , Oxidative Stress/drug effectsABSTRACT
Piper amalago L. (Piperaceae) is traditionally used due to its anti-inflammatory, analgesic, diuretic, and antiparasitic properties. However, few studies have focused on its adverse effects, compromising its safe use. This study evaluated the toxicological safety of ethanolic extract from Piper amalago leaves (EEPA), through subacute toxicity and genotoxicity assays in rodents. In subacute toxicity, 100, 200 or 300 mg/kg of EEPA were tested in female Wistar rats, by gavage, for 28 days. For genotoxicity test, female Swiss mice were orally treated with 17.5, 175 or 1750 mg/kg of EEPA and the comet, micronucleus, and splenic phagocytic assays were evaluated. In subacute toxicity, the extract induced an increase in the food and water intakes, as well as in the liver absolute weight, and in the heart and kidney relative weights. EEPA also provoked alterations in histopathological analysis of liver and in hemato-biochemical parameters, evidenced by a decrease in hematocrit levels and albumin levels, and an increase in the number of platelets and in alkaline phosphatase and cholesterol levels. However, EEPA did not presented genotoxic nor mutagenic properties. EEPA showed hemato-biochemical toxicity profile in rats and should be used with caution, especially when for prolonged period.
Subject(s)
Piper , Plant Extracts/pharmacology , Animals , Blood/drug effects , Blood Chemical Analysis , DNA Damage/drug effects , Dose-Response Relationship, Drug , Female , Liver/drug effects , Mice , Mutagenicity Tests , Plant Leaves , Random Allocation , Rats , Rats, Wistar , Toxicity Tests, SubacuteABSTRACT
Essential oils (EOs) are bioactive compounds with therapeutic potential for use as alternatives or as support to conventional treatments. However, EOs present limitations, such as sensibility to environmental factors, which can be overcome through microencapsulation. The objective of this study was to produce, by spray drying, chitosan microparticles (CMs) loaded with EO of Lemongrass (Cymbopogon flexuosus), Geranium (Pelargonium x ssp) and Copaiba (Copaifera officinalis). Physicochemical and biological characterization of these microparticles showed that CMs presented spherical morphology, had an average size range of 2-3 µm with positive zeta potential (ZP) values, and enhanced thermal stability, compared to free EO. The encapsulation efficiency (EE) ranged from 4.8-58.6%, depending on the oil's properties. In vitro EO release from CMs was determined at different pHs, with 94% release observed in acid media. All microparticles were non-hemolytic at concentrations of up to 0.1 mg·mL-1. EOs and CMs presented acetylcholinesterase (AChE) inhibition activity (IC 50 ranged from 11.92 to 28.18 µg·mL-1). Geranium and Copaiba EOs presented higher toxicity against Artemia salina, and greater inhibition of acetylcholinesterase, indicating potential bioactivity for Alzheimer's disease (AD). Our findings demonstrate that CM systems may show promise for the controlled release of these EOs.
Subject(s)
Artemia/drug effects , Capsules/chemistry , Chitosan/chemistry , Cholinesterase Inhibitors/pharmacology , Cymbopogon/chemistry , Fabaceae/chemistry , Oils, Volatile/analysis , Pelargonium/chemistry , Animals , Blood/drug effects , Cholinesterase Inhibitors/toxicity , Cymbopogon/toxicity , Fabaceae/toxicity , Hemolysis , Hot Temperature , Humans , Hydrogen-Ion Concentration , Inhibitory Concentration 50 , Microscopy, Electron, Scanning , Oils, Volatile/chemistry , Particle Size , Pelargonium/toxicity , Spectroscopy, Fourier Transform InfraredABSTRACT
Antipsychotics are the main line of treatment for schizophrenia, a disorder that affects about 1% of the worldwide population. Considering the poor performance of antipsychotics on patients, this work aimed at detecting alterations in the elemental profile resulting from the use of this type of medication using an elemental fingerprinting strategy. We evaluated 56 plasma samples from schizophrenia patients by inductively coupled plasma mass spectrometry (ICP-MS) before (t0) and after 6 weeks (t6) of treatment. The level of response of the patients (good vs. poor responders) and the medications taken were considered. Zinc, aluminum, phosphorus, and iron levels were found to be increased, whereas sodium, potassium, calcium, and magnesium levels decreased after treatment. Aluminum presented a higher level in poor responders at t0 when compared to good responders. At t6, iron showed an increased level when compared to t0 for good responders; however, its level remained constant in poor responders. The results of this exploratory study provide clues for further investigations on the role of metal ions in the treatment of schizophrenia.
Subject(s)
Antipsychotic Agents/pharmacology , Blood Chemical Analysis , Blood/drug effects , Mass Spectrometry/methods , Schizophrenia/blood , Schizophrenia/diet therapy , Spectrophotometry, Atomic/methods , Adult , Cohort Studies , HumansABSTRACT
Various studies on methylmercury (MeHg)-induced toxicity focused on the central nervous system (CNS) as a primary target. However, MeHg-mediated toxicity is related to metallic interaction with electrophilic groups, which are not solely restricted to the CNS, but these reactive groups are present ubiquitously in several systems/organs. The aim of this study was thus to examine MeHg-induced systemic toxicity in mice using a standardized neurotoxicology testing exposure model to measure cerebellar neurotoxicity by determining biochemical and behavioral parameters in the cerebellum. After 2 weeks exposure to MeHg (40 µg/ml; diluted in drinking water; ad libitum), adult male Swiss mice showed a marked motor impairment characteristic of cerebellar toxicity as noted in the following tests: rotarod, beam walking, pole, and hind limb clasping. MeHg treatment resulted in Hg deposition in the cerebellum as well as reduction in cerebellar weight, glutathione peroxidase (GPx) activity, and interleukin (IL)-6 levels. MeHg ingestion increased cerebellar glutathione reductase (GR) activity and brain-derived neurotrophic factor (BDNF) levels. In addition to cerebellar toxicity, MeHg treatment also elevated total and non-high density lipoprotein (non-HDL) cholesterol levels, as well as serum aspartate transaminase (AST) and alanine transaminase (ALT) enzymatic activities, systemic parameters. Increased liver weight and reduced serum urea levels were also noted in MeHg-exposed mice. Taken together, our findings demonstrated that a well-standardized exposure protocol to examine MeHg-induced neurotoxicity also produced systemic toxicity in mice, which was characterized by changes in markers of hepatic function as well as serum lipid homeostasis.
Subject(s)
Blood/drug effects , Cerebellum/drug effects , Environmental Pollutants/toxicity , Liver/drug effects , Methylmercury Compounds/toxicity , Motor Activity/drug effects , Animals , Blood Chemical Analysis , Cerebellum/metabolism , Liver/metabolism , Male , MiceABSTRACT
The aim of the study was to assess of occupational exposure to pesticides in rural workers using genotoxicity test, bioindicators and clinical evaluation. Blood, urine and buccal samples from persons, rural workers exposed to a complex mixture of pesticides with organophosphates (n=94) and without organophosphates (n=94) were collected to compare the activities of cholinesterases, the levels of urinary dialkyl phosphates, genotoxicity data, from a cytome assay. Biomarkers were analysed by traditional/published methods Control group consisted of 50 other persons, non- occupationally exposed to pesticides from the city of Alfenas, Minas Gerais, Brazil. All subjects underwent a clinical evaluation. In the group exposed to organophosphates, the activity of acetylcholinesterase, butyrylcholinesterase and total cholinesterase was lower by 63.8%, 12.8%, and 14.8%, respectively, and 92.6% of the group had dialkyl phosphates present in their urine. The cytome assay was used to measure biomarkers of DNA damage (micronuclei and/or elimination of nuclear material by budding), cytokinetic defects (binucleated cells), and proliferative potential (basal cell) and/or cell death (condensed chromatin, karyorrhectic, pyknotic, and karyolytic cells). The group exposed to organophosphates showed significant changes in all these parameters compared to the control group and showed significant changes in budding, condensed chromatin and karyolytic cells compared with the group non-exposed to organophosphates. Data from the clinical evaluation showed significant changes in the central nervous, respiratory and auditory systems. The studied biomarkers are able to distinguish occupational and environmental exposure to pesticides and the data showed hazardous exposure to organophosphates and afforded valuable data to estimate the risk to cancer development.
Subject(s)
Alkanes/analysis , Cholinesterases/metabolism , Occupational Exposure/adverse effects , Organophosphates/adverse effects , Pesticides/adverse effects , Adult , Alkanes/blood , Alkanes/urine , Blood/drug effects , Blood/metabolism , Brazil , DNA Damage , Female , Humans , Male , Micronucleus Tests , Middle Aged , Mouth/drug effects , Mouth/metabolism , Mutagenicity Tests , Rural Population , Urine/chemistryABSTRACT
Studies on caffeine consumption have shown a negative correlation with development of some diseases with subsequent beneficial manifestations. Our aim was to assess the effects of caffeine on peripheral blood and neural tissue DNA in young adult and aged mice. Male Swiss mice (age 2-3 or 16-18 months, respectively) were treated with a caffeine solution (0.3 g/l) for 4 weeks, while controls received water. After the treatments, blood and hippocampal cells (for a comet assay) and femurs (for a micronucleus [MN] test) were collected. The comet assay of peripheral blood and hippocampal cells demonstrated no significant differences between caffeine-treated and control young adult mice in terms of DNA damage index (DI) and frequency. In contrast, when comparing young adult with aged animals, significant differences were observed in DNA damage in blood and hippocampal cells. The differences between aged animals (with or without caffeine) consisted of a significant decrease in DNA DI in the group that received caffeine. In the MN test, an increase in frequency of micronucleated polychromatic (PCE) erythrocytes was noted in aged animals that received water compared to young adult mice. In addition, comparing treated with control aged murine groups, a decrease in frequency of MN was found in PCE erythrocytes of caffeine-treated mice. Chronic caffeine consumption was neither genotoxic nor mutagenic at the dose tested; however, it appears that caffeine actually protected mice from genotoxicity and mutagenicity, consequences attributed to aging.
Subject(s)
Blood/drug effects , Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , DNA Damage/drug effects , Nerve Tissue/drug effects , Age Factors , Animals , Blood/metabolism , Comet Assay , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mice , Micronucleus Tests , Nerve Tissue/metabolismABSTRACT
Cadmium is an environmental pollutant of increasing worldwide concern. It has been reported to be high in the soil where food crops are grown in some parishes of Jamaica. Surprisingly, no adverse effect of cadmium has been reported among the Jamaican population. However, phytic acid has also been shown to be high in some food crops grown in Jamaica. In this study, we evaluated the effects of phytic acid (1 %) and exercise on the metabolism of cadmium (5 mg cadmium/kg body weight) in rats. Five groups of rats were fed as follows: rats fed control diet, control diet supplemented with cadmium and subjected to exercise, control diet supplemented with phytic acid plus cadmium and subjected to exercise, control diet supplemented with cadmium plus phytic acid, and control diet supplemented with cadmium only. The animals were fed for 4 weeks and then sacrificed. Blood samples were collected for some biochemical assays. Percentage weight loss (28.42 %) was greatest in the group that had cadmium supplement only. The group fed control diet supplemented with cadmium only displayed increased liver enzymes and electrolytes except for the significant decrease in bicarbonate compared to other test groups. Similarly, blood urea nitrogen and uric acid were increased in the group fed cadmium supplement only compared to other test groups. Total cholesterol trended downwards in the test groups compared to control. These observations suggest that consumption of diet high in phytic acid with relatively high physical activity may be protective against the adverse effects of cadmium.
Subject(s)
Blood/metabolism , Cadmium/administration & dosage , Cadmium/adverse effects , Dietary Supplements , Physical Conditioning, Animal/physiology , Phytic Acid/pharmacology , Administration, Oral , Animals , Blood/drug effects , Blood Chemical Analysis , Cadmium/metabolism , Phytic Acid/administration & dosage , Rats , Rats, WistarABSTRACT
The aim of this work was to evaluate the hematological changes induced by Tityus serrulatus venom (TsV). Blood of Wistar rats was collected 0.5, 2, 6 and 24 h after i.p. injection of TsV (0.5 mg/kg) or saline (controls). Two additional groups were injected with 0.67 mg/kg and 0.25 mg/kg of TsV and the blood was collected after 0.5 and 2 h, respectively. The results showed an increase on hematocrit (Ht), red blood cells (RBC) count, hemoglobin concentration (Hb), albumin and total protein, mainly 2-6 h after envenoming. Increase in serum activities of amylase, creatine kinase and aspartate aminotransferase were also observed, indicating tecidual damages. Hyperglycemia was observed at all times analyzed, as a consequence of catecholamine release. No significant changes were detected in the urea, [Na(+)] and [Ca(2+)], but an increase of [Mg(2+)], [K(+)] and conductivity was observed. TsV induced a reduction of erythrocytes osmotic fragility as consequence of dehydration and increase in plasma electrolytes concentration, as evidenced by its higher conductivity. This study demonstrated that TsV is able to induce severe hematological changes, that appear within the first hours after envenoming, justifying the seeking of medical attention as soon as possible to avoid worsening of clinical symptoms.
Subject(s)
Scorpion Venoms/toxicity , Scorpions/chemistry , Albumins/metabolism , Animals , Blood/drug effects , Blood Proteins/metabolism , Erythrocyte Count , Hematocrit , Hemoglobins/metabolism , Osmotic Pressure , Rats , Rats, Wistar , Time Factors , Toxicity TestsABSTRACT
AIMS: the purpose of the present work was to investigate the effect of cyclooxygenase-2 (COX-2) inhibition on the cardiovascular and inflammatory aspects promoted by monosodium glutamate (MSG)-induced obesity in rats. MAIN METHODS: Neonatal Wistar male rats were injected with MSG (4 mg/g body weight ID) or equimolar saline (control). Treatment with celecoxib (50 mg/kg ip) or saline (0.9% NaCl ip) began at 60 days of age. At 90 days, all rats were anesthetized for catheterization of the femoral artery, and the mean arterial pressure (MAP) and heart rate (HR) were recorded once consciousness was regained. KEY FINDINGS: MSG obese rats were hypertensive (MAP=138±4 mm Hg) compared with controls (MAP=118±2 mm Hg). After treatment with celecoxib, the hypertension was attenuated (MAP=126±2 mm Hg) in obese rats without changes in HR. The retroperitoneal and periepididymal fat weighed more in obese rats (Obese: Retro=7.08±0.51, Peri=6.36±0.81, CONTROL: Retro=3.60±0.46; Peri=3.24±0.42), but celecoxib did not alter these parameters. Plasma nitric oxide levels were not different between groups. However, the level of plasma prostaglandins, the immunohistochemical staining of COX-2 in cardiac tissue and plasma lipoperoxidation were higher in obese rats, and celecoxib attenuated these parameters. MSG produced liver steatosis that was also attenuated following celecoxib treatment. SIGNIFICANCE: Our data demonstrate an association between increased blood pressure and products of COX-2 in obese rats, suggesting a role for prostaglandins in the hypertensive and inflammatory aspects of MSG-induced obesity.
Subject(s)
Cyclooxygenase 2 Inhibitors/therapeutic use , Hypertension/drug therapy , Obesity/chemically induced , Obesity/drug therapy , Sodium Glutamate/pharmacology , Adipose Tissue/pathology , Animals , Blood/drug effects , Blood Pressure/drug effects , Blood Pressure/physiology , Celecoxib , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Dinoprostone/blood , Heart/drug effects , Heart Rate/drug effects , Heart Rate/physiology , Hypertension/etiology , Hypertension/physiopathology , Inflammation/blood , Inflammation/drug therapy , Inflammation/etiology , Inflammation/metabolism , Lipid Peroxidation/drug effects , Lipid Peroxides/blood , Liver/drug effects , Liver/pathology , Male , Myocardium/metabolism , Nitrates/blood , Obesity/complications , Obesity/metabolism , Obesity/pathology , Obesity/physiopathology , Pyrazoles/pharmacology , Pyrazoles/therapeutic use , Rats , Rats, Wistar , Sulfonamides/pharmacology , Sulfonamides/therapeutic useABSTRACT
The anti-inflammatory drugs possess many serious side effects at doses commonly prescribed. It is really important to discover novel regulators of inflammation from natural sources with minimal adverse effects. Schinus areira L. is a plant native from South America and is used in folk medicine as an anti-inflammatory herb. For this study, the activity of aqueous extracts on inflammation and the effect on superoxide anion production in mice macrophages were assayed. Aqueous extracts were prepared by soaking herbs in cold water (cold extract), boiling water (infusion), and simmering water (decoction). Cold extract possess an anti-inflammatory activity. Decoction and infusion showed pro-inflammatory activity. Cold extract increased the production of superoxide anion. It has been proposed to use diverse methods to obtain extracts of S. areira L. with different effects. Cold extract, decoction, and infusion could be utilized as extracts or as pharmacological preparations for topical application.
Subject(s)
Anacardiaceae/chemistry , Anti-Inflammatory Agents/pharmacology , Inflammation Mediators/pharmacology , Inflammation/chemically induced , Inflammation/prevention & control , Plant Extracts/pharmacology , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/therapeutic use , Blood/drug effects , Carrageenan/pharmacology , Cell Survival/drug effects , Ear/pathology , Edema/chemically induced , Edema/pathology , Edema/prevention & control , Female , Foot/pathology , Inflammation/pathology , Inflammation Mediators/administration & dosage , Inflammation Mediators/isolation & purification , Interleukin-10/blood , Interleukin-6/blood , Interleukin-6/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Male , Mice , Mice, Inbred Strains , Plant Components, Aerial/chemistry , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Respiratory Burst/drug effects , Respiratory Burst/immunology , Superoxides/metabolism , Tetradecanoylphorbol Acetate/administration & dosage , Tetradecanoylphorbol Acetate/pharmacology , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/metabolism , Zymosan/immunology , Zymosan/pharmacologyABSTRACT
PURPOSE: The aim of this study was to investigate the impact of granulocyte-colony stimulating factor (G-CSF) administration on cardiac function of rats with chronic myocardial infarction through two different protocols: high dose short term and low dose long term protocols. METHODS: Wistar rats were submitted to MI surgery and after 4 weeks they received recombinant human G-CSF (Filgrastim) or vehicle subcutaneously. We tested the classical protocol (50 microg/kg/day during 7 days) and the long term low dose treatment (four cycles of 5 days of 10 microg/kg/day). Cardiac performance was evaluated before, 4 and 6 weeks after G-CSF injections by electro- and echocardiography, hemodynamic and treadmill exercise test. RESULTS: All infarcted groups exhibited impaired function compared to sham operated animals. Moreover, all cardiac functional parameter were not different between G-CSF and Vehicle group at resting conditions as well as after treadmill exercise stress test, despite intense white blood cell mobilization in both protocols at all time points. Hypertrophy was not different and infarct size was similar in histological analysis CONCLUSIONS: These data clearly show that G-CSF treatment was unable to restore cardiac function impaired by myocardial infarction either with classical approach or long term low dose administration.
Subject(s)
Granulocyte Colony-Stimulating Factor/therapeutic use , Myocardial Infarction/drug therapy , Animals , Blood/drug effects , Blood Pressure , Cell Count , Echocardiography , Electrocardiography , Exercise Test , Filgrastim , Granulocyte Colony-Stimulating Factor/administration & dosage , Granulocyte Colony-Stimulating Factor/pharmacology , Granulocytes/cytology , Heart/drug effects , Heart/physiopathology , Hematopoietic Stem Cells/cytology , Hemodynamics/physiology , Leukocyte Count , Male , Myocardial Contraction/physiology , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocardium/pathology , Rats , Rats, Wistar , Recombinant Proteins , Ventricular Dysfunction, Left/pathology , Ventricular Dysfunction, Left/physiopathologyABSTRACT
BACKGROUND: The SR-BI is a key component on the cholesterol metabolism. Polymorphisms in the SR-BI gene (SCARB1) were related with variations on plasma lipoprotein profile and other risk factors for cardiovascular disease. We tested the relationship of 3 SCARB1 single nucleotide polymorphisms (SNPs) with hypercholesterolemia in a Brazilian population and whether these variants can influence lipid-lowering response to atorvastatin. METHODS: c.4G>A, c.726+54C>T and c.1050C>T SNPs and serum concentrations of lipid and apolipoproteins were evaluated in 147 hypercholesterolemic (HC) and 185 normolipidemic (NL) unrelated Brazilian subjects. HC patients were treated with atorvastatin (10 mg/day/4 weeks). RESULTS: Frequencies of SCARB1 polymorphisms were similar between the HC and NL groups (p>0.05). The T allele for c.726+54C>T was associated with higher LDL-c in NL and with higher apoB and apoB/apoAI in HC (p<0.05). HC individuals carrying c.1050C allele carriers (CC and CT genotypes) had lower change of total cholesterol, LDL-c, apoB and apoB/apoAI ratio (p<0.05) than the TT genotype carriers in response to atorvastatin. CONCLUSION: The SCARB1 polymorphisms are related with variations in serum lipids in the Brazilian population and c.1050C>T SNP is associated with lipid-lowering atorvastatin response.
Subject(s)
Heptanoic Acids/therapeutic use , Hypercholesterolemia/drug therapy , Hypercholesterolemia/genetics , Lipids/blood , Polymorphism, Single Nucleotide/genetics , Pyrroles/therapeutic use , Scavenger Receptors, Class B/genetics , Adult , Aged , Aged, 80 and over , Anticholesteremic Agents/therapeutic use , Apolipoprotein A-I/blood , Apolipoproteins B/blood , Atorvastatin , Blood/drug effects , Brazil , Cholesterol/blood , Cholesterol/metabolism , Cholesterol, HDL/blood , Cholesterol, HDL/drug effects , Cholesterol, HDL/genetics , Cholesterol, LDL/blood , Cholesterol, LDL/drug effects , Cholesterol, LDL/genetics , Female , Gene Frequency/genetics , Genotype , Haplotypes/genetics , Humans , Hypercholesterolemia/blood , Linkage Disequilibrium/genetics , Lipid Metabolism/drug effects , Lipid Metabolism/genetics , Male , Middle Aged , Triglycerides/bloodABSTRACT
OBJECTIVE: To evaluate the effects of arginine on intestinal barrier integrity and bacterial translocation (BT) in mice undergoing intestinal obstruction. METHODS: Mice were divided into 3 groups, treated for 7 d before surgical intervention with isocaloric and isoprotein diets. The ARG group received a diet containing 2% arginine, the IO (intestinal obstruction) and Sham groups, standard chow diet. On the eighth day of treatment, all animals received diethylenetriamine pentaacetic acid (DTPA) solution labeled with 99mTechnetium (99mTc-DTPA) by gavage for intestinal permeability analysis. After 90 min, the animals were anesthetized and the terminal ileum ligated. The Sham group only underwent laparotomy. After 4, 8, and 18 h, blood was collected for radioactivity determination. Samples of ileum were collected 18 h after surgery for histological analysis. In another set of animals, BT was evaluated. After 7 d of treatment, all animals received 10(8) CFU/mL of 99mTc-E.coli by gavage; 90 min later they were submitted to the surgical procedure described above. BT was determined by the uptake of 99mTc-E.coli in blood, mesenteric lymph nodes, liver, spleen, and lungs, assessed 18 h after the surgery. RESULTS: The intestinal permeability and BT were higher in the IO group when compared with the Sham group (P < 0.05). Arginine supplementation reduced intestinal permeability and BT to physiologic levels. Histological analysis showed mucosal ileum preservation in animals treated with arginine. CONCLUSION: Arginine was able to preserve barrier integrity, thus reducing BT.
Subject(s)
Arginine/pharmacology , Bacterial Translocation/drug effects , Escherichia coli/physiology , Intestinal Mucosa/drug effects , Intestinal Obstruction , Animals , Arginine/administration & dosage , Blood/drug effects , Blood/microbiology , Diet , Escherichia coli Infections/prevention & control , Ileum/drug effects , Ileum/microbiology , Ileum/pathology , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Isotopes , Liver/drug effects , Liver/microbiology , Lung/drug effects , Lung/microbiology , Lymph Nodes/drug effects , Lymph Nodes/microbiology , Mice , Pentetic Acid , Permeability , Spleen/drug effects , Spleen/microbiology , TechnetiumABSTRACT
This study was designed to assess the effect of Cadmium (Cd) and lead (Pb) exposure during pregnancy in rats and their correlation with metallothionein (MT). Rats were exposed to either 10 ppm Cd or 300 ppm Pb through drinking water during pregnancy. Both metals were measured in placenta, fetus brain and fetal and maternal blood. MT was quantified in placenta and fetus brain and it was also observed in placenta by immunohistochemical technique. Offspring weight was found to be significantly lower for the Cd exposure group than for the control group. A Cd increase in the placenta of the exposed group was accompanied by MT induction; these effects were related to a limited accumulation of Cd in fetus brain. In contrast, dam Pb exposure caused an accumulation of Pb in the fetus brain and induced damage to placenta. The results account for differences in the transference of these metals during pregnancy that could be related to their toxicity.
Subject(s)
Cadmium/pharmacology , Lead/pharmacology , Metallothionein/metabolism , Administration, Oral , Animals , Birth Weight/drug effects , Blood/drug effects , Brain/drug effects , Cadmium/analysis , Calibration , Cattle , Dose-Response Relationship, Drug , Female , Fetus , Immunohistochemistry , Lead/analysis , Maternal-Fetal Exchange , Metallothionein/analysis , Placenta/drug effects , Pregnancy , Quality Control , Rats , Reference Standards , Spectrophotometry, Atomic/methodsABSTRACT
In the present article, we report data on the possible antigenotoxic activity of Mikania laevigata extract (MLE) after acute intratracheal instillation of coal dust using the comet assay in peripheral blood, bone marrow, and liver cells and the micronucleus test in peripheral blood of Wistar rats. The animals were pretreated for 2 weeks with saline solution (groups 1 and 2) or MLE (100 mg/kg) (groups 3 and 4). On day 15, the animals were anesthetized with ketamine (80 mg/kg) and xylazine (20 mg/kg), and gross mineral coal dust (3 mg/0.3 mL saline) (groups 2 and 4) or saline solution (0.3 mL) (groups 1 and 3) was administered directly in the lung by intratracheal administration. Fifteen days after coal dust or saline instillation, the animals were sacrificed, and the femur, liver, and peripheral blood were removed. The results showed a general increase in the DNA damage values at 8 hours for all treatment groups, probably related to surgical procedures that had stressed the animals. Also, liver cells from rats treated with coal dust, pretreated or not with MLE, showed statistically higher comet assay values compared to the control group at 14 days after exposure. These results could be expected because the liver metabolizes a variety of organic compounds to more polar by-products. On the other hand, the micronucleus assay results did not show significant differences among groups. Therefore, our data do not support the antimutagenic activity of M. laevigata as a modulator of DNA damage after acute coal dust instillation.
Subject(s)
Antimutagenic Agents/pharmacology , Coal/adverse effects , DNA Damage/drug effects , Dust , Mikania , Plant Extracts/pharmacology , Animals , Blood/drug effects , Bone Marrow/drug effects , Comet Assay/methods , Environmental Exposure/adverse effects , Femur/drug effects , Hepatocytes/drug effects , Liver/drug effects , Male , Micronucleus Tests/methods , Plant Components, Aerial , Rats , Rats, WistarABSTRACT
Baccharis dracunculifolia (D.C.) (Asteraceae), a native plant to Brazil known as "vassourinha" or "alecrim-do-campo", is the most important botanical source of a Brazilian propolis called green propolis. The leaf extracts of this plant have been used to treat liver and digestive disorders. It has been recognized that green propolis can induce mutagenic effects at high doses, but no study reporting possible mutagenic effects by Baccharis dracunculifolia extracts in the maximum tolerated dose has been conducted. The aim of the present study was to investigate the genotoxic and mutagenic effects of this plant in vivo. Adult CF-1 mice were treated with 0.5g/kg, 1.0g/kg or 2.0g/kg of an aqueous extract of Baccharis dracunculifolia by gavage for 3 consecutive days. Blood and liver samples were collected to detect DNA damage using the comet assay, while bone marrow samples were used to assess chromosome mutations by the micronucleus test. The extract increased the DNA damage in blood and liver tissues and the frequency of micronucleus in bone marrow. These findings suggest genotoxic and mutagenic effects of Baccharis dracunculifolia comparable to green propolis in mice.
Subject(s)
Baccharis , Bone Marrow/drug effects , DNA Damage , Mutagenesis/drug effects , Mutagens/toxicity , Plant Extracts/toxicity , Animals , Blood/drug effects , Chromosomes/drug effects , Female , Liver/drug effects , Mice , Micronucleus Tests , Plant Components, Aerial , Propolis/toxicityABSTRACT
Objetivos: Quantificar e avaliar os efeitos adversos causados pelo uso de acitretina e metotrexato o tratamento da psoríase. Material e métodos: Foi realizada uma coorte histórica para avaliação de intervenção em pacientes com uso de metotrexato e acitretina para tratamento de psoríase. Resultados: Foram revisados os prontuários de 101 pacientes, com um total de 127 tratamentos, tendo sido avaliadas as variáveis sexo, idade, tipo clínico de psoríase, medicação utilizada, dose média, tempo de uso, hepatotoxicidade, mielotoxicidade, nefrotoxicidade, alterações nos lipídeos e comorbidades. A incidência de hepatotoxicidade no grupo todo foi de 8,7% (11/127), sendo de 9% (4/44) no grupo do acitretina e 10,5% (6/58) no grupo do metotrexato. Mielotoxicidade teve incidência de 6% (8/127) em todo o grupo, 2% (1/44) no grupo do acitretina e 10,5% (6/58) no do metotrexato. Hiperlipidemia apresentou incidência de 34% (15/44) nos pacientes em uso de acitretina e 7% (4/58) nos que utilizaram metotrexato, sendo este o efeito adverso mais importante da acitretina (p=0,002). Alterações renais não foram encontradas. Conclusão: A principal diferença encontrada pelo estudo foi entre hiperlipidemia causada por acitretina em relação ao metotrexato. Na amostra estudada não foi observada diferença estatisticamente significativa entre as drogas quanto à hepatotoxicidade e à mielotoxicidade. Os resultados do estudo permitem inferir que o metotrexato, medicação acessível, de baixo custo e bem conhecida do meio médico, demonstra perfil de toxicidade aceitável quando usado em determinadas doses, podendo ter seu uso preferencial cogitado, especialmente em contexto de assistência no setor público
Objectives: To quantify and evaluate the adverse effects caused by acitretine and methotrexate when treating psoriasis. Methods: A retrospective cohort study was performed to evaluate an intervention in patients using methotrexate and acitretine to treat psoriasis. Results: The records of 101 patients were reviewed, with a total of 127 treatments, and the following variables were evaluated: sex, age, clinical type of psoriasis, medication used, mean dose, time of use, hepatotoxicity, myelotoxicity, nephrotoxicity, alterations in the lipids and comorbidities. The rate of occurrence of hepatotoxicity in the group as a whole was 8.7% (11/127), 9% (4/44) in the acitretine group and 10.5% (6/58) in the methotrexate group. Myelotoxicity had a rate of occurrence of 6% (8/127) in the group as a whole, 2% (1/44) in the acitretine group and 10.5% (6/58) in the methotrexate one. The presence of hyperlipidemia was observed in 34% (15/44) of the patients who used acitretine, and in 7% (4/58) of those who used methotrexate, and this was the most important adverse effect of acitretine (p=0.002). No renal alterations were found. Conclusion: Themain difference found by the study was between hyperlipidemia caused by acitretine compared to methotrexate. In the sample studied no statistically significant difference was observed between the drugs as to hepatotoxicity and myelotoxicity. The results of the study allow the inference that methotrexate, a low-cost medication, well-known in the medical world, shows an acceptable toxicity profile, and its preferential use can be considered, especially in a context of public care
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Psoriasis/drug therapy , Methotrexate/adverse effects , Acitretin/adverse effects , Psoriasis/blood , Psoriasis/epidemiology , Blood/drug effects , Bone Marrow/drug effects , Brazil/epidemiology , Methotrexate/therapeutic use , Retrospective Studies , Acitretin/therapeutic use , Hypercholesterolemia/chemically induced , Kidney/drug effects , Liver/drug effectsABSTRACT
BACKGROUND: Methylphenidate (MPH) is a widely prescribed psychostimulant for the treatment of attention-deficit hyperactivity disorder (ADHD). Recently, some studies have addressed the genotoxic potential of the MPH, but the results have been contradictory. Hence, the present study aimed to investigate the index of cerebral and peripheral DNA damage in young and adult rats after acute and chronic MPH exposure. METHODS: We used (1) single cell gel electrophoresis (Comet assay) to measure early DNA damage in hippocampus, striatum and total blood, and (2) micronucleus test in total blood samples. RESULTS: Our results showed that MPH increased the peripheral index of early DNA damage in young and adult rats, which was more pronounced with chronic treatment and in the striatum compared to the hippocampus. Neither acute nor chronic MPH treatment increased micronucleus frequency in young or in adult rats. Peripheral DNA damage was positively correlated with striatal DNA damage. CONCLUSION: These results suggest that MPH may induce central and peripheral early DNA damage, but this early damage may be repaired.
Subject(s)
Brain/drug effects , Central Nervous System Stimulants/pharmacology , DNA Damage/drug effects , Methylphenidate/pharmacology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Blood/drug effects , Comet Assay/methods , Dose-Response Relationship, Drug , Drug Administration Schedule , Micronucleus Tests/methods , Rats , Rats, WistarABSTRACT
This study evaluated the influence of diets supplemented with 500, 800, 1200 mg kg-1 of vitamin C (ascorbic acid or AA) and vitamin E (alpha-tocopherol or alpha-T) on the physiological responses of pirarucu fed for 2 months. Weight and mortality were not affected by dietary vitamin type or their concentrations. Significant increase (p<0.05) on the red blood cells count was obtained on treatments with 800 and 1200 mg AA kg-1 and on the hemoglobin concentration on treatment with 500 mg alpha-T kg-1 relatively to control. Mean corpuscular volume presented a significant decrease (p<0.05) on treatment with 800 and 1200 mg AA kg-1 when compared to control. Mean corpuscular hemoglobin concentration was significantly high (p<0.05) on treatment with 500 mg alpha-T kg-1. Only in vitamin C treatments, we noticed a significant increase (p<0.05) in the number of leucocytes relative to control. All fish in the vitamin-supplemented treatments, except 500 mg AA kg-1, had high total protein values compared to control. Fish treated with 800 or 1200 mg alpha-T kg-1 also showed increases in plasma glucose concentrations. Our results suggest that 800 and 1200 mg AA kg-1 are probably the most suitable concentrations for pirarucu diets, although high vitamin E diets are not necessary for quantitative leucocyte increases for this species.